| domain | spryson.com |
| summary | NeuroAI has received FDA Breakthrough Designation, which will expedite its path to regulatory approval. Their recent research, published in *Experimental Brain Research*, titled “Oculomotor, Vestibular, Reaction Time, and Cognitive OVRT-C Responses in 7- to 17-Year-Old Children,” utilizes eye-tracking, balance, reaction time, and cognitive assessments to advance research in pediatric brain health, concussion recovery, and cognitive development, solidifying NeuroAI’s technology as a leading tool for AI-driven diagnostics. |
| title | Home - Spryson America |
| description | Home - Spryson America |
| keywords | research, technology, tracking, data, more, time, menu, platform, concussion, check, diagnostics, real, detection, objective, main, chair, breakthrough |
| upstreams |
|
| downstreams |
|
| nslookup | A 162.159.135.42 |
| created | 2025-11-10 |
| updated | 2026-01-27 |
| summarized | 2026-01-31 |
|
|